Diabetes and hypertension are associated with lowered cognitive performance among middle-aged Brazilian adults
cross-sectional analyses nested in the longitudinal Pró-Saúde study
Palavras-chave:
Cognition, Diabetes mellitus, Hypertension, Middle-aged, BrazilResumo
BACKGROUND: Cardiovascular risk factors are frequently associated with lowered cognitive performance among elderly people, but rarely among middle-aged adults. OBJECTIVES: To investigate associations between cardiovascular risk factors (age, physical inactivity, smoking, alcohol use, hypertension and diabetes) and lower cognitive performance among middle-aged (45-64 years) Brazilian adults. DESIGN AND SETTING: Cross-sectional study nested within the Pró-Saúde cohort. From 2,876 baseline study participants (1999), we randomly selected 488 participants and gave them validated and standardized cognitive tests (2012). METHODS: We used multiple linear and logistic regression analyses to detect associations of cardiovascular risk factors with crude scores in cognitive tests on memory (word test) and executive function (verbal fluency tests), and with overall cognitive performance scores, respectively. RESULTS: All cognitive test scores presented statistically significant inverse associations with age and direct associations with education. There was no association between lower cognitive performance and smoking or alcohol use. In both 1999 and 2012, after adjusting for sex, age and schooling, being physically active was inversely associated with lower performance regarding late memory. For individuals with diabetes in 1999, there was an association with lower performance regarding executive function, while there was a borderline association for those reporting it only in 2012. Having a diagnosis of hypertension since 1999 was associated with lower performance regarding both memory and executive functions, while reporting hypertension in 2012 was associated with lower performance regarding executive function. CONCLUSIONS: Aging, low schooling and cardiovascular risk factors may represent life course disadvantages associated with cognitive decline even among middle-aged Brazilian adults.
Downloads
Referências
GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer’s disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(1):88-106. PMID: 30497964; https://doi.org/10.1016/S1474-4422(18)30403-4.
de la Torre JC. Vascular risk factor detection and control may prevent Alzheimer’s disease. Ageing Res Rev. 2010;9(3):218-25. PMID: 20385255; https://doi.org/10.1016/j.arr.2010.04.002.
Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology. 2001;56(1):42-8. PMID: 11148234; https://doi.org/10.1212/wnl.56.1.42.
Cukierman T, Gerstein HC, Williamson JD. Cognitive decline and dementia in diabetes--systematic overview of prospective observational studies. Diabetologia. 2005;48(12):2460-9. PMID: 16283246; https://doi.org/10.1007/s00125-005-0023-4.
Rawlings AM, Sharrett AR, Schneider AL, et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med. 2014;161(11):785-93. PMID: 25437406; https://doi.org/10.7326/M14-0737.
Teixeira MM, Passos VMA, Barreto SM, et al. Association Between Diabetes and Cognitive Function at Baseline in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil). Scientific reports. 2020; 10(1):1596. PMID: 32005901; https://doi.org/10.1038/s41598-020-58332-9.
Duncan BB, Schmidt MI, Cousin E, et al. The burden of diabetes and hyperglycemia in Brazil-past and present: findings from the Global Burden of Disease Study 2015. Diabetol Metab Syndr. 2017;9:18. PMID: 28293304; http://dx.doi.org/10.1590/1980-5497201700050008.
Marinho MFM, Passos VMA, Malta DA, et al. Burden of disease in Brazil, 1990-2016: a systematic subnational analysis for the Global Burden of Disease Study 2016. Lancet. 2018;392(10149):760-75. PMID: 30037735; https://doi.org/10.1016/S0140-6736(18)31221-2.
Victora CG, Barreto ML, do Carmo LM, et al. Health conditions and health-policy innovations in Brazil: the way forward. Lancet. 2011;377(9782):2042-53. PMID: 21561659; https://doi.org/10.1016/S0140-6736(11)60055-X.
Faerstein E, Chor D, Lopes CS, et al. Estudo Pró-Saúde: características gerais e aspectos metodológicos. Rev Bras Epidemiol.
American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019;42(Suppl 1):S13-S28. PMID: 30559228; https://doi.org/10.2337/dc19-S002.
UNESCO. International Standard Classification of Education 1997. Available from: http://uis.unesco.org/sites/default/files/documents/international-standard-classification-of-education-1997-en_0.pdf. Accessed in 2020 (May 11).
Bertolucci PHF, Okamoto IH, Toniolo Neto J. et al. Desempenho da população brasileira na bateria neuropsicológica do Consortium to Establish a Registry for Alzheimer’s Disease (CERAD) [Performance of Brazilian population in neuropsychological battery of Consortium to Establish a Registry for Alzheimer’s disease]. Rev Psiquiatr Clín. 1998;25(2):80-3. LILACS | ID: lil-225833.
Batista JA, Giatti L, Barreto SM, Galery ARP, Passos VMA. Reliability of Cognitive tests of Elsa-Brasil, the Brazilian Longitudinal Study of Public Health. Dement Neuropsychol. 2013;7(4):367-73. PMID: 29213860; https://doi.org/10.1590/S1980-57642013DN74000003.
de Azeredo Passos VM, Giatti L, Bensenor I, et al. Education plays a greater role than age in cognitive test performance among participants of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). BMC Neurol. 2015;15:191. PMID: 26452731; https://doi.org/10.1186/s12883-015-0454-6.
STATA, Data analysis and Statistical Software: College Station, Texas, USA: Stata Corporation; version 12.
Pagano M, Gauvreau K. Principles of biostatistics. USA: Thomson Learning; 2004.
Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012;344:d7622. PMID: 22223828; https://doi.org/10.1136/bmj.d7622.
Winkler A, Dlugaj M, Weimar C, et al. Association of diabetes mellitus and mild cognitive impairment in middle-aged men and women. J Alzheimer’s Dis. 2014;42(4):1269-77. PMID: 25024326; https://doi.org/10.3233/JAD-140696.
McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet. 2012;16;379(9833):2291-9. PMID: 22683129; https://doi.org/10.1016/S0140-6736(12)60360-2.
Guerchet M, Mbelesso P, Ndamba-Bandzouzi B, et al. Epidemiology of dementia in Central Africa (EPIDEMCA): protocol for a multicentre population-based study in rural and urban areas of the Central African Republic and the Republic of Congo. 2014; 3;3(1):338. PMID: 25045613; https://link.springer.com/article/10.1186/2193-1801-3-338.
Bertola L, Benseñor IM, Barreto SM, et al. Measurement invariance of neuropsychological tests across different sociodemographic backgrounds in the Brazilian Longitudinal Study of Adult Health (ELSA- Brasil). Neuropsychology. 2020;34(2):227-234. PMID: 31829661; https://doi.org/10.1037/neu0000597.
Li W & Huang E. An Update on Type 2 Diabetes Mellitus as a Risk Factor for Dementia. J Alzheimers Dis. 2016;53(2):393-402. PMID: 27163819; https://doi.org/10.3233/JAD-160114.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
